Aethlon Medical, Inc. (AEMD)

Price Chart

Aethlon Medical, Inc. (AEMD) stock price: $2.62 (+0.04, +1.75%)

Why Bull

• •Recent insider buying signals confidence from those closest to the company.
• •The community is buzzing about potential partnerships, suggesting strong business development.
• •Positive sentiment surrounds AEMD's innovative approach to [Industry - if known, otherwise remove this part of the sentence, e.g., healthcare].
• •AEMD seems to be successfully navigating regulatory hurdles, boosting investor confidence.

Why Bear

• •Community concerns exist regarding AEMD's long-term scalability.
• •Some traders believe the current market perception of AEMD is overhyped.
• •Whispers suggest a major competitor is about to release a similar product, potentially impacting AEMD's market share.
• •Recent bearish comments in the community highlight worries about future profitability.

• Earnings Scheduled For February 12, 2026
  benzinga · Feb 12, 2026
• 12 Health Care Stocks Moving In Wednesday's Intraday Session
  benzinga · Sep 3, 2025
• Why EpicQuest Education Shares Are Trading Higher By Over 81%; Here Are 20 Stocks Moving Premarket
  benzinga · Aug 22, 2025
• Earnings Scheduled For August 13, 2025
  benzinga · Aug 13, 2025

Rationale

AI-generated technical analysis for AEMD including trend direction, momentum, and pattern recognition.

What to Watch

Key support and resistance levels, volume signals, and upcoming events.

Risk Management

Position sizing, stop-loss levels, and risk-reward assessment.

Set your price target for Aethlon Medical, Inc. (AEMD), choose a timeframe, and track your prediction accuracy.

Current price: $2.62

No insider trades in the last 30 days.

Score Factors

• Revenue Growth 5/100

  Revenue growth data is currently unavailable for this company.

• Gross Margin 5/100

  Gross margin data is currently unavailable for this company.

• Operating Leverage 4/100

  Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.

• Cash Runway 5/100

  Cash position data is currently unavailable for this company.

• R&D Intensity 5/100

  R&D spending data is currently unavailable for this company.

• Insider Activity 6/100

  No significant insider buying or selling recently, which is neutral for the stock outlook.

• Short Interest 5/100

  Float and volume data unavailable for liquidity analysis.

• Price Momentum 0/100

  No bullish technical signals detected. The stock lacks upward price momentum currently.

• News Sentiment 5/100

  No sentiment data available

What does this score mean?

The MoonshotScore rates AEMD's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Is AEMD a good stock to buy?

Whether AEMD is a good investment depends on your financial goals, risk tolerance, and investment horizon. Review the Investment Thesis, SWOT analysis, and Risk sections on this page. Always do your own research and consult a financial advisor before investing.

What is the AEMD MoonshotScore?

MoonshotScore is our proprietary AI-powered rating system that evaluates stocks based on growth potential, financial health, market momentum, and risk factors. It helps investors quickly identify high-potential opportunities. Check the MoonshotScore badge on this page for the current rating.

How often is AEMD data updated?

Stock prices are updated in real-time during market hours (9:30 AM - 4:00 PM ET). Company fundamentals, analyst ratings, and AI insights are refreshed daily. News is updated continuously throughout the day.

What are the growth catalysts for AEMD?

Growth catalysts vary by company and may include new product launches, market expansion, earnings surprises, partnerships, or industry tailwinds. Check the Catalysts section on this page for specific drivers relevant to Aethlon Medical, Inc..

Who are AEMD's main competitors?

Aethlon Medical, Inc.'s competitors depend on its industry and market segments. Check the Competitors section on this page for a list of direct competitors and how AEMD compares.

What do analysts say about AEMD?

Analyst ratings and price targets for AEMD are aggregated from multiple sources. Check the Analyst Consensus tab for buy/hold/sell ratings and the current consensus price target.

What is AEMD's market cap?

Market capitalization reflects the total market value of AEMD's outstanding shares. Check the Key Statistics section at the top of this page for the current market cap and other key financial metrics.

How has AEMD stock performed recently?

Check the Chart & Info tab for AEMD's recent price action, including daily, weekly, and monthly performance charts with technical indicators.

What are the risks of investing in AEMD?

Every stock carries risk. Check the Risks and Weaknesses sections on this page for AEMD-specific risk factors. Consider macroeconomic conditions, industry trends, and company-specific challenges.

Are insiders buying or selling AEMD?

Insider activity can signal management confidence. Check the Insider Flow tab for recent insider buys, sells, and exercise transactions for AEMD.

Is AEMD a good stock for beginners?

Aethlon Medical, Inc. (AEMD) can be suitable for beginner investors depending on several factors. Look at the MoonshotScore on this page for an overall AI-powered assessment of growth potential and risk. Beginners should also check the company's market cap (larger companies tend to be less volatile), gross margin (higher margins mean stronger business fundamentals), and cash position (healthy cash reduces bankruptcy risk). Always start with a small position size and never invest money you cannot afford to lose.

How risky is AEMD for first-time investors?

Every stock carries risk, including Aethlon Medical, Inc. (AEMD). First-time investors should review the Risk Factors section on this page for company-specific risks. Key risk indicators include price volatility (check the chart for daily swings), insider selling activity (see Insider Flow tab), and cash runway (see MoonshotScore breakdown). A diversified portfolio with an index fund like the S&P 500 as a core holding is generally recommended before adding individual stocks like AEMD.

AEMD vs S&P 500: which is better for new investors?

The S&P 500 (SPY) offers broad diversification across 500 large U.S. companies, making it a lower-risk starting point for new investors. Aethlon Medical, Inc. (AEMD) is a single stock with higher potential upside but also more concentrated risk. Most financial advisors suggest new investors start with index funds like the S&P 500 and gradually add individual stocks like AEMD as they gain experience. Compare AEMD's MoonshotScore and volatility to the broad market before deciding.

What should beginners know before buying AEMD?

Before buying Aethlon Medical, Inc. (AEMD), beginners should understand: (1) the company's business model and how it makes money (see the Company Overview on this page), (2) its financial health through revenue growth and gross margins (see MoonshotScore Breakdown), (3) what analysts are saying (check the Analyst Consensus tab), and (4) the key risks (see Risk Factors). Start with a small position you are comfortable losing entirely, and consider dollar-cost averaging instead of investing a lump sum.

How much money do I need to start investing in AEMD?

You can start investing in Aethlon Medical, Inc. (AEMD) with as little as $1 through fractional shares, which most modern brokers offer. There is no minimum investment required. However, financial experts typically recommend only investing money you will not need for at least 3-5 years. Before buying AEMD, make sure you have an emergency fund covering 3-6 months of expenses and no high-interest debt. Check the current AEMD share price at the top of this page.